Getinge AB (GNGBF) Q4 2024 Earnings Call Highlights: Strong Sales Growth and Strategic Shifts [Yahoo! Finance]
GETINGE AB UNSP/ADR (GNGBY)
NASDAQ:AMEX Investor Relations:
getinge.com/int/about-us/investors
Company Research
Source: Yahoo! Finance
4 min read In This Article GNGBY Order Intake Growth: 11% overall growth, with 7.4% organic growth. Net Sales Growth: Increased by 11.8%, with 9.2% organic growth. Adjusted Gross Profit: Increased by SEK1 billion to SEK5.6 billion. Adjusted EBITDA: SEK2.143 billion, with a margin of 19.4%. Free Cash Flow: Increased by more than 70% to around SEK1.7 billion. Net Debt: SEK10.5 billion, adjusted to SEK7.8 billion excluding pension liabilities. Leverage: 1.6 times adjusted EBITDA, 1.2 times when adjusted for perpetual liabilities. Dividend Proposal: SEK4.60 per share, representing 38% of free cash flow per share. Paragonix Technologies Contribution: Net sales growth of about 65%, contributing approximately SEK240 million. Surgical Perfusion Net Sales: SEK450 million in 2024, with restructuring costs estimated at SEK800 million. Warning! GuruFocus has detected 7 Warning Signs with GNGBF. Release Date: January 28, 2025 For the complete transcript of the earnin
Show less
Read more
Impact Snapshot
Event Time:
GNGBY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GNGBY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GNGBY alerts
High impacting GETINGE AB UNSP/ADR news events
Weekly update
A roundup of the hottest topics
GNGBY
News
- Does Getinge's 29.3% Rally Signal Room for Growth After Healthcare Sector Headlines? [Yahoo! Finance]Yahoo! Finance
- North America Heart Pump Device Market Forecast and Company Analysis Report 2025-2033 Featuring Abbott, Getinge, Teleflex, Fresenius, LivaNova, CorWave, JARVIK HEART, ABIOMED [Yahoo! Finance]Yahoo! Finance
- Getinge (OTCMKTS:GNGBY) was upgraded by analysts at Nordea Equity Research from a "hold" rating to a "buy" rating.MarketBeat
- Paragonix Technologies' KidneyVault® System Safely Transports Donor Kidney from Arizona to Puerto Rico [Yahoo! Finance]Yahoo! Finance
- Patient Handling Equipment Market Size Projected to Reach USD 23.95 Billion by 2034 Amid Rising Chronic Diseases and Smart Healthcare Innovations [Yahoo! Finance]Yahoo! Finance